Karuna Therapeutics to Announce First Quarter 2023 Financial Results and Provide General Business Update on Thursday, May 4, 2023

Rhea-AI Summary

Karuna Therapeutics (NASDAQ: KRTX) will hold a conference call and webcast on May 4, 2023, at 8:00 a.m. ET to discuss its first quarter 2023 financial results and provide a general business update.

The live webcast will be available on the Investor Relations page of Karuna’s website, and a replay will be accessible for up to 30 days after the event. Karuna Therapeutics focuses on developing innovative treatments for psychiatric and neurological disorders, aiming to address the unmet needs of patients facing these challenges.

Conference call and webcast to take place on Thursday, May 4, 2023 at 8:00 a.m. ET

BOSTON--(BUSINESS WIRE)-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it will host a live conference call and webcast on Thursday, May 4, 2023 at 8:00 a.m. ET to review first quarter 2023 financial results and provide a general business update.

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the completion of the event.

About Karuna Therapeutics

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230420005407/en/

Investors:

Alexis Smith

+1 (518) 338-8990

asmith@karunatx.com



Media:

Bob Josefsberg

+1 (646) 734-3584

bjosefsberg@karunatx.com

Source: Karuna Therapeutics, Inc.

FAQ

When is Karuna Therapeutics' conference call?

Karuna Therapeutics' conference call is scheduled for May 4, 2023, at 8:00 a.m. ET.

Where can I access the webcast for Karuna Therapeutics' financial results?

The webcast will be available on the Investor Relations page of Karuna's website.

What will be discussed during the conference call by Karuna Therapeutics?

The conference call will cover the first quarter 2023 financial results and a general business update.